A carregar...
Duration of natalizumab therapy and reasons for discontinuation in a multiple sclerosis population
OBJECTIVE: To determine multiple sclerosis patient characteristics that predict a shorter duration of natalizumab treatment. METHODS: The Tysabri Outreach: Unified Commitment to Health database was reviewed to identify patients treated with natalizumab at our centers. Cox proportional hazards models...
Na minha lista:
| Publicado no: | Mult Scler J Exp Transl Clin |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6987494/ https://ncbi.nlm.nih.gov/pubmed/32064117 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2055217320902488 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|